CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 110 enrolled
Drug / intervention
Antegrade Intramedullary Nail +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00593333
NCT00593333N/ACompleted

Intramedullary Nailing of the Femur: A Comparison of the Trochanteric and Piriformis Starting Portals

University of Alabama at Birmingham·interventional·Posted Jan 15, 2008·Updated Jun 5, 2017

In Brief

A clinical study evaluating Antegrade Intramedullary Nail and Trigen Trochanteric Femoral Nail for Femur Fracture. Completed, enrolled 110 participants across 1 site.

Detailed Summary

This project is designed to determine whether or not the trochanteric insertion portal will show any difference when compared with the piriformis fossa portal in terms of pain and strength of the hip abductor muscles, while allowing faster surgical fixation of the femur fracture.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFemur Fracture
CountriesUnited States

Timeline

N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 15, 2008
Enrollment StartJun 1, 2003
Primary CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 18.5 years ago

Interventions

Antegrade Intramedullary Naildevice

Use of an antegrade intramedullary nail implanted through the Piriformis fossa of the femur. The use of these nails has yielded a union rate of 97 - 99%, and has clearly become the most commonly utilized implant for femur fractures.

Trigen Trochanteric Femoral Naildevice

Antegrade intramedullary nails developed with a proximal lateral bend that allows implantation through the greater trochanter rather than the piriformis fossa. This start portal is remarkably easier to locate and may be associated with decreased risk of abductor muscle weakness and pain.